Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)
26.89
+0.14 (0.52%)
Apr 30, 2025, 3:04 PM CST
SHE:002864 Revenue
In the year 2024, Shaanxi Panlong Pharmaceutical Group Limited By Share had annual revenue of 973.86M CNY, down -0.71%. Shaanxi Panlong Pharmaceutical Group Limited By Share had revenue of 250.21M in the quarter ending March 31, 2025, with 19.08% growth.
Revenue
973.86M
Revenue Growth
-0.71%
P/S Ratio
2.90
Revenue / Employee
1.13M
Employees
864
Market Cap
2.83B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 973.86M | -6.96M | -0.71% |
Dec 31, 2023 | 980.83M | 6.53M | 0.67% |
Jan 1, 2023 | 974.29M | 86.81M | 9.78% |
Jan 1, 2022 | 887.48M | 217.17M | 32.40% |
Dec 31, 2020 | 670.31M | 59.68M | 9.77% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |